A prospective randomized controlled clinical study for the effect of preoperative butorphanol combined with penehyclidine hydrochloride

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026570

Enrollment

Unknown

Registered

2019-10-14

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse drug reactions

Interventions

B group:Preoperative intravenously injected with Butorphanol 1 mg

BP group:Preoperative intravenously injected with Butorphanol 1 mg and Penehyclidine Hydrochloride 0.01 mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18~65 years. 2) BMI 18.5-24. 3) Selective surgery patients who are planning to undergo arterial puncture and catheterization for manometry. 4) ASA grade I~II.

Exclusion criteria

Exclusion criteria: 1) Drug contraindications 2) Thyroid disease. 3) Dermatosis. 4) Fever. 5) Diseases affecting metabolism. 6) Can not cooperate with the research, etc..

Design outcomes

Primary

Measure	Time frame
sweating or not;temperature;	—

Secondary

Measure	Time frame
Adverse reactions;	—

Countries

China

Contacts

Public ContactWei Zhang

The First Affiliated Hospital of Zhengzhou University

doctor_anwx@163.com+86 15003995323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026